Piriou E, Kimmel R, Chelimo K, Middeldorp JM, Odada PS, Ploutz-Snyder R, et al. Serological evidence for long-term Epstein–Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol. 2009;81(6):1088–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biggar RJ, Henle W, Fleisher G, Bocker J, Lennette ET, Henle G. Primary Epstein–Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer. 1978;22(3):239–43.

Article  CAS  PubMed  Google Scholar 

Piriou E, Asito AS, Sumba PO, Fiore N, Middeldorp JM, Moormann AM, et al. Early age at time of primary Epstein–Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis. 2012;205(6):906–13.

Article  PubMed  PubMed Central  Google Scholar 

Slyker JA, Casper C, Tapia K, Richardson B, Bunts L, Huang ML, et al. Clinical and virologic manifestations of primary Epstein–Barr virus (EBV) infection in Kenyan infants born to HIV-infected women. J Infect Dis. 2013;207(12):1798–806.

Article  PubMed  PubMed Central  Google Scholar 

de The G, Day NE, Geser A, Lavoue MF, Ho JH, Simons MJ, et al. Sero-epidemiology of the Epstein–Barr virus: preliminary analysis of an international study - a review. IARC Sci Publ. 1975;11:3–16.

Google Scholar 

Asito AS, Piriou E, Odada PS, Fiore N, Middeldorp JM, Long C, et al. Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt’s lymphoma patients: a case control study. Infect Agent Cancer. 2010;5:13.

Article  PubMed  PubMed Central  Google Scholar 

Cao SM, Liu Z, Jia WH, Huang QH, Liu Q, Guo X, et al. Fluctuations of Epstein–Barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up. PLoS ONE. 2011;6(4):e19100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carpenter LM, Newton R, Casabonne D, Ziegler J, Mbulaiteye S, Mbidde E, et al. Antibodies against malaria and Epstein–Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer. 2008;122(6):1319–23.

Article  CAS  PubMed  Google Scholar 

Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, et al. Serologic markers of Epstein–Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med. 2001;345(26):1877–82.

Article  CAS  PubMed  Google Scholar 

Evans AS, Gutensohn NM. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin’s disease and their siblings. Int J Cancer. 1984;34(2):149–57.

Article  CAS  PubMed  Google Scholar 

Geser A, de The G, Lenoir G, Day NE, Williams EH. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt’s lymphoma. Int J Cancer. 1982;29(4):397–400.

Article  CAS  PubMed  Google Scholar 

Hardell K, Carlberg M, Hardell L, Bjornfoth H, Ericson Jogsten I, Eriksson M, et al. Concentrations of organohalogen compounds and titres of antibodies to Epstein–Barr virus antigens and the risk for non-Hodgkin lymphoma. Oncol Rep. 2009;21(6):1567–76.

Article  CAS  PubMed  Google Scholar 

Ji MF, Wang DK, Yu YL, Guo YQ, Liang JS, Cheng WM, et al. Sustained elevation of Epstein–Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br J Cancer. 2007;96(4):623–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levin LI, Chang ET, Ambinder RF, Lennette ET, Rubertone MV, Mann RB, et al. Atypical prediagnosis Epstein–Barr virus serology restricted to EBV-positive Hodgkin lymphoma. Blood. 2012;120(18):3750–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levine PH, Stemmermann G, Lennette ET, Hildesheim A, Shibata D, Nomura A. Elevated antibody titers to Epstein–Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int J Cancer. 1995;60(5):642–4.

Article  CAS  PubMed  Google Scholar 

Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, et al. Hodgkin’s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med. 1989;320(11):689–95.

Article  CAS  PubMed  Google Scholar 

Mueller N, Mohar A, Evans A, Harris NL, Comstock GW, Jellum E, et al. Epstein–Barr virus antibody patterns preceding the diagnosis of non-Hodgkin’s lymphoma. Int J Cancer. 1991;49(3):387–93.

Article  CAS  PubMed  Google Scholar 

Mueller NE, Lennette ET, Dupnik K, Birmann BM. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis. Int J Cancer. 2012;130(12):2886–91.

Article  CAS  PubMed  Google Scholar 

Mutalima N, Molyneux E, Jaffe H, Kamiza S, Borgstein E, Mkandawire N, et al. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS ONE. 2008;3(6):e2505.

Article  PubMed  PubMed Central  Google Scholar 

Rothman N, Cantor KP, Blair A, Bush D, Brock JW, Helzlsouer K, et al. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet. 1997;350(9073):240–4.

Article  CAS  PubMed  Google Scholar 

Shinkura R, Yamamoto N, Koriyama C, Shinmura Y, Eizuru Y, Tokunaga M. Epstein–Barr virus-specific antibodies in Epstein–Barr virus-positive and -negative gastric carcinoma cases in Japan. J Med Virol. 2000;60(4):411–6.

Article  CAS  PubMed  Google Scholar 

Xu J, Ahmad A, Blagdon M, D’Addario M, Jones JF, Dolcetti R, et al. The Epstein–Barr virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases. Int J Cancer. 1998;79(5):481–6.

Article  CAS  PubMed  Google Scholar 

Yu KJ, Hsu WL, Pfeiffer RM, Chiang CJ, Wang CP, Lou PJ, et al. Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families. Clin Cancer Res. 2011;17(7):1906–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wabinga HR, Nambooze S, Amulen PM, Okello C, Mbus L, Parkin DM. Trends in the incidence of cancer in Kampala, Uganda 1991–2010. Int J Cancer. 2014;135(2):432–9.

Article  CAS  PubMed  Google Scholar 

Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. Br J Cancer. 2000;82(9):1585–92.

CAS  PubMed  PubMed Central  Google Scholar 

Biological agents. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1–441.

Mutyaba I, Wabinga HR, Orem J, Casper C, Phipps W. Presentation and outcomes of childhood cancer patients at Uganda Cancer Institute. Glob Pediatr Health. 2019;6:2333794X19849749.

PubMed  PubMed Central  Google Scholar 

Stefan C, Bray F, Ferlay J, Liu B, Maxwell PD. Cancer of childhood in sub-Saharan Africa. Ecancermedicalscience. 2017;11:755.

Article  PubMed  PubMed Central  Google Scholar 

Asiki G, Murphy G, Nakiyingi-Miiro J, Seeley J, Nsubuga RN, Karabarinde A, et al. The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies. Int J Epidemiol. 2013;42(1):129–41.

Article  PubMed  PubMed Central  Google Scholar 

Nunn AJ, Kengeya-Kayondo JF, Malamba SS, Seeley JA, Mulder DW. Risk factors for HIV-1 infection in adults in a rural Ugandan community: a population study. AIDS. 1994;8(1):81–6.

Article  CAS  PubMed  Google Scholar 

Newton R, Labo N, Wakeham K, Miley W, Asiki G, Johnston WT, et al. Kaposi sarcoma-associated herpesvirus in a rural Ugandan cohort, 1992–2008. J Infect Dis. 2018;217(2):263–9.

Article  CAS  PubMed  Google Scholar 

Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, et al. Single-assay combination of Epstein–Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening. J Clin Microbiol. 2006;44(4):1459–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mbisa GL, Miley W, Gamache CJ, Gillette WK, Esposito D, Hopkins R, et al. Detection of antibodies to Kaposi’s sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. J Immunol Methods. 2010;356(1–2):39–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morgan D, Malamba SS, Maude GH, Okongo MJ, Wagner HU, Mulder DW, et al. An HIV-1 natural history cohort and survival times in rural Uganda. AIDS. 1997;11(5):633–40.

Article  CAS  PubMed  Google Scholar 

World Health Organization. Interim WHO clinical staging of HVI/AIDS and HIV/AIDS case definitions for surveillance: African region. Geneva: World Health Organization; 2005.